menu
    • menu

    Company profile for Crescendo Biologics Ltd

    NEW Drugs in Dev: 3
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Crescendo Biologics develops potent, multi-functional Humabody® therapeutics with a focus on novel targeted T-cell engagement. Using our proprietary transgenic mouse platform, we have created a tumour-targeted T-cell engager mechanism capable of activating T-cells only in the tumour microenvironment. Our ability to configure unique therapeutic formats allows Humabodies to engage targets in ways that generates new biology thro...
    Crescendo Biologics develops potent, multi-functional Humabody® therapeutics with a focus on novel targeted T-cell engagement. Using our proprietary transgenic mouse platform, we have created a tumour-targeted T-cell engager mechanism capable of activating T-cells only in the tumour microenvironment. Our ability to configure unique therapeutic formats allows Humabodies to engage targets in ways that generates new biology through novel target engagement. Our transgenic VH platform enables us to create an almost limitless number of mono- and multi-functional constructs capable of engaging therapeutically valuable targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Crescendo Biologics Ltdunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Meditrina Building 260, Babraham Research Campus, Cambridge, CB22 3AT
    Telephone
    Telephone
    +44 (0) 1223 497140
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.crescendobiologics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/crescendo-biologics-ltd
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/humabody

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crescendo announces first U.S. patients dosed in Phase 1b trial of CB307
    Crescendo announces first U.S. patients dosed in Phase 1b trial of CB307

    06 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/12/06/2791637/0/en/Crescendo-Biologics-announces-first-U-S-patients-dosed-in-expanded-Phase-1b-clinical-trial-of-CB307-for-patients-with-mCRPC.html

    GLOBENEWSWIRE
    06 Dec 2023
    Share Share
    Crescendo Biologics Secures $32M to Expand CB307 Trial
    Crescendo Biologics Secures $32M to Expand CB307 Trial

    25 Jul 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-07-25/crescendo-biologics-secures-32m-to-expand-cb307-trial/?widget=listSection

    CONTRACT PHARMA
    25 Jul 2023
    Share Share
    Crescendo secures $32M and announces expansion of CB307 Ph 1b trial
    Crescendo secures $32M and announces expansion of CB307 Ph 1b trial

    24 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230724740688/en

    BUSINESSWIRE
    24 Jul 2023
    Share Share
    Angle PLC Announces Pharma Services Contract with Crescendo Biologics
    Angle PLC Announces Pharma Services Contract with Crescendo Biologics

    13 Apr 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=748999&lang=en

    ACCESSWIRE
    13 Apr 2023
    Share Share
    Angle PLC, Crescendo Biologics Ink Clinical Services Contract
    Angle PLC, Crescendo Biologics Ink Clinical Services Contract

    13 Apr 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-04-13/angle-plc-announces-pharma-services-contract-with-/?widget=listSection

    CONTRACT PHARMA
    13 Apr 2023
    Share Share
    BioNTech builds to a Crescendo with $750M cancer research pact
    BioNTech builds to a Crescendo with $750M cancer research pact

    10 Jan 2022

    // Kyle LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/biontech-its-way-to-deal-crescendo-a-750m-biobucks-pact-for-immunotherapies

    Kyle LaHucik FIERCEBIOTECH
    10 Jan 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search